Insulin-like growth factors (IGF-I, free IGF-I, and IGF-II) and insulin- like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation

Journal of Clinical Laboratory Analysis

Volumn 13, Issue 4, 1999, Pages 166-172

  Yu, Herbert ^a   Mistry, Jehangir ^b   Nicar, Michael J ^b   Khosravi, M Javad ^c   Diamandis, Anastasia ^c   Van Doorn, Jaap ^d   Juul, Anders ^e  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b Diagnostic Systems Laboratories Inc   (United States)

^c Diagnostic Systems Laboratories   (Canada)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e Rigshospitalet   (Denmark)

Author keywords

ALS; Free IGF I; IGFBP 2; IGFBP 3; IGFBP 6; IGFs

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C;

ADULT; ARTICLE; BODY GROWTH; HUMAN; LABORATORY TEST; NORMAL HUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

ADULT; BLOOD CIRCULATION; BLOOD PROTEINS; CARRIER PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOASSAY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; PROTEIN BINDING; RECEPTORS, SOMATOMEDIN; REFERENCE VALUES; SOMATOMEDINS;

EID: 0032993673     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1999)13:4<166::AID-JCLA5>3.0.CO;2-X     Document Type: Article

References (36)

1. Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 1989;10:68-90.
2. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological antions. Endocr Rev 1995;16:3-34.
3. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer 1992;65:311-320.
4. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 1995;16:143-163.
5. Shimasaki S, Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Prog Growth Factor Res 1991;1:243-266.
6. Baxter RC. Characterization of the acid-labile subunit of the growth hormone dependent insulin-like growth factor binding protein complex. J Clin Endocrinol Metab 1988;67:265-272.
7. Baxter RC, Martin JL, Beniac VA. High molecular weight insulin-like growth factor binding protein complex, purification properties of the acid-labile subunit from human serum. J Biol Chem 1989;264:11843-11848.
8. Cuneo RC, Hickman PE, Wallace JD, et al. Altered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease. Clin Endocr 1995;43:265-275.
9. Holt RI, Jones JS, Stone NM, Baker AJ, Miell JP. Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation. J Clin Endocrinol Metab 1996;81:160-168.
10. Rosenfeld RG, Wilson DM, Lee PDK, Hintz RL. Insulin-like growth factors I and II in evaluation of growth retardation. J Pediatr 1986;109:428-433.
11. Cohen P, Rosenfeld RG. Physiologic and clinical relevance of the insulin-like growth factor binding proteins. Curr Opin Pediatr 1994; 6:462-167.
12. Clemmons DR, Van Wyk JJ, Ridgway EC, Kliman B, Kjellberg RN, Underwood LE. Evaluation of acromegaly by radio-immunoassay of somatomedin-C. N Engl J Med 1979;301:1138-1142.
13. Jorgensen JO, Moller N, Moller J, Weeke J, Blum WF. Insulin-like growth factors (IGF)-I and -II and IGF binding protein-1, -2, and -3 in patients with acromegaly before and after adenomectomy. Metabolism 1994; 43:579-583.
14. Hankinson S, Willett WC, Colditz GA, et al. Circulating concentration of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393-1396.
15. Bruning PF, van Doorn J, Bonfrer JMG, et al. Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int J Cancer 1995;62:266-270.
16. Chan JM, Stampfer MJ, Giovannucci E, et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998;279:563-566.
17. Wolk A, Mantzoros CS, Andersson SO, et al. Insulin-like growth factor 1 and prostate cancer risk: a population-based case-control study. J Natl Cancer Inst 1998;90:911-915.
18. Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X. High plasma levels of insulin-like growth factor-I in association with lung cancer risk, a case-control analysis. J Natl Cancer Inst 1999;91:151-156.
19. Van Hooft IM, Grobbee, DE, Hofman A, Valkenberg HA. Early prediction of primary hypertension: an epidemiological approach. Int J Epidemiol 1988;17:228-229.
20. Van Hooft IM, Schiffers P, Grobbee DE, Rahn KH, Hofman A. Similar plasma atrial natriuretic factor levels in children and young adults with a high and low probability of developing hypertension: the Dutch hypertension and offspring study. J Hypertens Suppl 1989;7:43-44.
21. Juul A, Holm K, Kastrup KW, et al. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endocrinol Metab 1997;82:2497-2502.
22. Juul A, Moller S, Mosfeldt-Laursen E, et al. The acid-labile subunit of human ternary insulin-like growth factor binding protein complex in serum: hepatosplanchnic release, diurnal variation, circulating concentrations in healthy subjects and diagnostic use in patients with GH deficiency. J Clin Endocrinol Metab 1998;83:4408-4415.
23. Khosravi MJ, Diamandi A, Mistry J, Lee PDK. Noncompetitive ELISA for human serum insulin like growth factor-I. Clin Chem 1996;42:1147-1154.
24. Khosravi MJ, Diamandi A, Mistry J, Krishna RG, Khare A. Acid-labile subunit of human insulin-like growth factor-binding protein complex: measurement, molecular, and clinical evaluation. J Clin Endocrinol Metab 1997;82:3944-3951.
25. Juul A, Dalgaard P, Blum WF, et al. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995;80:2534-2542.
26. Argente J, Barrios V, Pozo J, et al. Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age- and sex-related changes. J Clin Endocrinol Metab 1993;77:1522-1528.
27. Porch JV, Jain K, Reilly A, et al. Aging, physical activity, insulin-like growth factor I, and body composition in Guatemalan women. Am J Clin Nutrit 1997;66:874-879.
28. Nystrom FH, Ohman PK, Ekman BA, Osterlund MK, Karlberg BE, Arnqvist HJ. Population-based reference values for IGF-I and IGF-binding protein-1: relations with metabolic and anthropometric variables. Euro J Endocrinol 1997;136:165-172.
29. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, et al. Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol 1994;41:351-357.
30. Kitano M, Shimizu T, Yamazaki Y, Umezu Y, Arakawa Y, Daimon Y. Serum insulin-like growth factor-I (IGF-I) in normal Japanese adults. Endocr J 1995;42:767-770.
31. Juul A, Bang P, Hertel NT, et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994;78:744-752.
32. Blum WF, Norn N, Kratzsch J, et al. Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regul 1993;3:100-104.
33. th annual meeting of the Endocrine Society, program and abstracts; 1998.
34. Thoren M, Hilding A, Baxter RC, Degerblad M, Wivall-Helleryd IL, Hall K. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency. J Clin Endocrinol Metab 1997;82:223-228.
35. Arai T, Busby W, Clemmons DR. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. Endocrinology 1996;137:4571-4575.
36. Russo VC, Bach LA, Fosang AJ, Baker NL, Werther GA. Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb. Endocrinology 1997;138:4858-4867.